Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$610.3K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 22 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 26,400 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 26,125 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 28,500 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 6,500 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 80,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | UTENDR | 20,628 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS | 82,374 | — | — | -80.0% | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | AGRANT | 39,456 | — | — | +62.1% | Open the original filing on SEC.gov |
| Jul 3, 2025 | BPMC | Blueprint Medicines Corp | SSELL | 1,172 | $128.25 | $150.3K | -1.8% | Open the original filing on SEC.gov |
| Jun 11, 2025 | XLO | Xilio Therapeutics, Inc. | AGRANT◆ | 31,000 | — | — | — | Open the original filing on SEC.gov |
| May 19, 2025 | BPMC | Blueprint Medicines Corp | SSELL◷ | 57 | $101.72 | $5.8K | <0.1% | Open the original filing on SEC.gov |
| May 19, 2025 | BPMC | Blueprint Medicines Corp | SSELL◷ | 1,413 | $100.67 | $142.2K | -2.1% | Open the original filing on SEC.gov |
| May 19, 2025 | BPMC | Blueprint Medicines Corp | SSELL◷ | 804 | $100.14 | $80.5K | -1.2% | Open the original filing on SEC.gov |
| May 5, 2025 | BPMC | Blueprint Medicines Corp | SSELL◷ | 144 | $103.56 | $14.9K | -0.2% | Open the original filing on SEC.gov |
| May 5, 2025 | BPMC | Blueprint Medicines Corp | SSELL◷ | 180 | $102.82 | $18.5K | -0.3% | Open the original filing on SEC.gov |
| May 5, 2025 | BPMC | Blueprint Medicines Corp | SSELL◷ | 1,343 | $101.77 | $136.7K | -2.0% | Open the original filing on SEC.gov |
| May 5, 2025 | BPMC | Blueprint Medicines Corp | SSELL◷ | 607 | $100.97 | $61.3K | -0.9% | Open the original filing on SEC.gov |